HALO AI

Looking Back: Reviewing 2025 at Indica Labs

As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.

Looking Back: Reviewing 2025 at Indica Labs Read More »

Advancing Neuroscience Research with HALO® and HALO AI

As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges to traditional histological analysis.

Advancing Neuroscience Research with HALO® and HALO AI Read More »

Unlocking the Potential of Antibody-Drug Conjugates (ADC) with HALO® Image Analysis and Indica Labs Pharma Services

Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy.

Unlocking the Potential of Antibody-Drug Conjugates (ADC) with HALO® Image Analysis and Indica Labs Pharma Services Read More »

Indica Labs’ London HALO® User Group Meeting 2025

9 December 2025 | Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on 9 December from 12:00 – 16:00 Lunch will be provided to all pre-registered attendees.

Indica Labs’ London HALO® User Group Meeting 2025 Read More »

Scroll to Top